A Single-Dose, Open-Label, Extension Study to Evaluate the Sustainability of the Effects of SYN-010 in Patients With Irritable Bowel Syndrome With Constipation
Phase of Trial: Phase II
Latest Information Update: 17 Jun 2017
At a glance
- Drugs Lovastatin (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- Sponsors Synthetic Biologics
- 23 May 2016 According to a Synthetic Biologics media release, results from this trial were presented at Digestive Disease Week (DDW 2016).
- 23 May 2016 Results published in a Synthetic Biologics media release.
- 05 May 2016 Detailed data will be presented at the Digestive Disease Week 2016, according to a Synthetic Biologics media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History